These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29303022)

  • 21. Differential interleukin (IL)-10 and IL-13 gene expression in vivo in salivary glands and peripheral blood mononuclear cells from patients with primary Sjögren's syndrome.
    Villarreal GM; Alcocer-Varela J; Llorente L
    Immunol Lett; 1996 Jan; 49(1-2):105-9. PubMed ID: 8964596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardamonin suppresses nitric oxide production via blocking the IFN-γ/STAT pathway in endotoxin-challenged peritoneal macrophages of ICR mice.
    Takahashi A; Yamamoto N; Murakami A
    Life Sci; 2011 Aug; 89(9-10):337-42. PubMed ID: 21784080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of cyclophosphamide on cytokines in patients with primary Sjögren's syndrome-associated interstitial lung disease].
    Mo HY; Wang LF; Xu J; Shi YH; Yang M; Zhou RH
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jul; 34(7):495-9. PubMed ID: 22041773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome.
    Boumba D; Skopouli FN; Moutsopoulos HM
    Br J Rheumatol; 1995 Apr; 34(4):326-33. PubMed ID: 7788146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential involvement of the IL-33-ST2 axis in the pathogenesis of primary Sjogren's syndrome.
    Awada A; Nicaise C; Ena S; Schandéné L; Rasschaert J; Popescu I; Gangji V; Soyfoo MS
    Ann Rheum Dis; 2014 Jun; 73(6):1259-63. PubMed ID: 24385203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ex vivo all-trans retinoic acid modulates NO production and regulates IL-6 effect during rheumatoid arthritis: a study in Algerian patients.
    Arroul-Lammali A; Rahal F; Chetouane R; Djeraba Z; Medjeber O; Ladjouze-Rezig A; Touil-Boukoffa C
    Immunopharmacol Immunotoxicol; 2017 Apr; 39(2):87-96. PubMed ID: 28211306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced expression of NLRP3 inflammasome-related inflammation in peripheral blood mononuclear cells in Sjögren's syndrome.
    Kim SK; Choe JY; Lee GH
    Clin Chim Acta; 2017 Nov; 474():147-154. PubMed ID: 28965771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local and Systemic IKKε and NF-κB Signaling Associated with Sjögren's Syndrome Immunopathogenesis.
    Chen W; Lin J; Cao H; Xu D; Xu B; Xu L; Yue L; Sun C; Wu G; Qian W
    J Immunol Res; 2015; 2015():534648. PubMed ID: 26380323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of M1/M2 macrophage polarization in primary Sjogren's syndrome.
    Chen X; Zhu L; Wu H
    Arthritis Res Ther; 2024 May; 26(1):101. PubMed ID: 38745331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of G
    Sun Y; Wang Y; Chen S; Fan G; Zhang J; Dai F; Qian H; Liu Y; Shi G
    J Immunol Res; 2018; 2018():8212641. PubMed ID: 29977933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant expression of the innate restriction factor bone marrow stromal antigen-2 in primary Sjögren's syndrome.
    Chen C; Shi H; Wang B; Cao N; Yu C; Zheng L
    J Craniomaxillofac Surg; 2018 Nov; 46(11):1899-1904. PubMed ID: 30249485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The tolerogenic peptide hCDR1 immunomodulates cytokine and regulatory molecule gene expression in blood mononuclear cells of primary Sjogren's syndrome patients.
    Sthoeger Z; Sharabi A; Asher I; Zinger H; Segal R; Shearer G; Elkayam O; Mozes E
    Clin Immunol; 2018 Jul; 192():85-91. PubMed ID: 29730433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased B-cell activating factor, interleukin-6, and interleukin-8 in induced sputum from primary Sjögren's syndrome patients.
    Nilsson AM; Tufvesson E; Hesselstrand R; Olsson P; Wollmer P; Mandl T
    Scand J Rheumatol; 2019 Mar; 48(2):149-156. PubMed ID: 30270699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
    Rim HK; Cho W; Sung SH; Lee KT
    J Pharmacol Exp Ther; 2012 Sep; 342(3):654-64. PubMed ID: 22637723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased CD200 levels in peripheral blood mononuclear cells of patients with primary Sjögren's syndrome.
    Liu TT; Zeng XP; Gu ML; Deng AM
    Int J Rheum Dis; 2020 May; 23(5):654-660. PubMed ID: 32180363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of cytokines in labial gland of Sjögren's syndrome].
    Ding D; Dong Y; Li S
    Zhonghua Yi Xue Za Zhi; 1996 Jun; 76(6):427-30. PubMed ID: 9275485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1,25-dihydroxyvitamin D3 regulates t helper and b lymphocyte responses substantially in drug-naive primary Sjögren’s syndrome patients’ mononuclear cells.
    Genç D; Sezer Kürkçü M; Günaydın B; Tarhan EF
    Turk J Med Sci; 2021 Oct; 51(5):2467-2476. PubMed ID: 34118806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DXXK exerts anti-inflammatory effects by inhibiting the lipopolysaccharide-induced NF-κB/COX-2 signalling pathway and the expression of inflammatory mediators.
    Yu Y; Li X; Qu L; Chen Y; Dai Y; Wang M; Zou W
    J Ethnopharmacol; 2016 Feb; 178():199-208. PubMed ID: 26571085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sophoraflavanone G prevents Streptococcus mutans surface antigen I/II-induced production of NO and PGE2 by inhibiting MAPK-mediated pathways in RAW 264.7 macrophages.
    Cha SM; Cha JD; Jang EJ; Kim GU; Lee KY
    Arch Oral Biol; 2016 Aug; 68():97-104. PubMed ID: 27111520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA Neat1 positively regulates MAPK signaling and is involved in the pathogenesis of Sjögren's syndrome.
    Ye L; Shi H; Yu C; Fu J; Chen C; Wu S; Zhan T; Wang B; Zheng L
    Int Immunopharmacol; 2020 Nov; 88():106992. PubMed ID: 33182021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.